Prime Capital Investment Advisors’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.9K | Sell |
24,124
-11,583
| -32% | -$14.4K | ﹤0.01% | 931 |
|
|
2025
Q1 | $42.1K | Buy |
35,707
+370
| +1% | +$437 | ﹤0.01% | 1027 |
|
|
2024
Q4 | $64.7K | Buy |
+35,337
| New | +$64.7K | ﹤0.01% | 905 |
|
|
2023
Q3 | – | Sell |
-19,286
| Closed | -$257K | – | 782 |
|
|
2023
Q2 | $257K | Sell |
19,286
-1,747
| -8% | -$23.2K | 0.01% | 648 |
|
|
2023
Q1 | $244K | Buy |
+21,033
| New | +$244K | 0.01% | 471 |
|